Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |